Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein kinase cAMP-dependent X-linked catalytic subunit (PRKX) is a serine/threonine kinase distinct from classical PKA, PKB/Akt, PKC, SGK, and PKG families but shares the property of cAMP-dependent activation. It plays roles in cellular signaling related to kidney development, epithelial morphogenesis, and granulocyte/macrophage maturation. PRKX is implicated in various developmental processes, sexual differentiation, and angiogenesis, and aberrant expression is associated with autosomal dominant polycystic kidney disease, sex reversal disorders due to abnormal recombination, and some cancers. While functionally distinct, PRKX overlaps mechanistically with PKA but with notable substrate and regulatory differences, and is considered an enzyme of emerging biomedical interest[1][2][4][5][6].
Not established for any approved drugs. As a kinase, potential modulators would theoretically act as kinase inhibitors or activators, influencing phosphorylation of downstream substrates[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein kinase cAMP-dependent X-linked catalytic subunit (PRKX).